Skip to content

Exelixis EXEL Available-for-Sale Securities (Non-Current)

Available-for-Sale Securities (Non-Current) at other companies

Teradyne, Inc. logo
Teradyne, Inc.TER
$148.37M+30.4%
Paychex logo
PaychexPAYX
$0-100%
eBay logo
eBayEBAY
$2.01B-22.3%
Teradyne, Inc. logo
Teradyne, Inc.TER
$3.65M-88.6%
SS&C Technologies logo
SS&C TechnologiesSSNC
$172.8M-0.7%
Starwood Property Trust logo
Starwood Property TrustSTWD
$308.2M-38.0%

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesNoncurrent.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's available-for-sale securities (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's available-for-sale securities (non-current)?
Exelixis (EXEL) reported available-for-sale securities (non-current) of $649.14M in Q1 2026.
How has Exelixis's available-for-sale securities (non-current) changed year-over-year?
Exelixis's available-for-sale securities (non-current) increased by 4.8% year-over-year, from $619.44M to $649.14M.
What is the long-term trend for Exelixis's available-for-sale securities (non-current)?
Over 2 years (2023 to 2025), Exelixis's available-for-sale securities (non-current) has grown at a -9.0% compound annual growth rate (CAGR), from $728.72M to $603.6M.